The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ma Songjiang since 2024.
This trader's CIK number is 1985547.
At the time of last reporting, Ma Songjiang was the President of Gyre Therapeutics, Inc.. (stock ticker symbol GYRE).
Also see all insider trading activities at Gyre Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | GYRE | 0 | $0 | 116,383 | $1,314,918 | 0 | $0 |
| 2024 | GYRE | 0 | $0 | 4,000 | $45,450 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-27 | GYRE | Sale | 2,000 | 10.28 | 20,560 |
| 2025-05-28 | GYRE | Sale | 558 | 10.07 | 5,619 |
| 2025-05-22 | GYRE | Sale | 2,000 | 10.97 | 21,940 |
| 2025-05-23 | GYRE | Sale | 182 | 10.24 | 1,863 |
| 2025-05-20 | GYRE | Sale | 2,000 | 11.25 | 22,500 |
| 2025-05-21 | GYRE | Sale | 2,000 | 10.83 | 21,660 |
| 2025-05-19 | GYRE | Sale | 2,000 | 11.11 | 22,220 |
| 2025-05-16 | GYRE | Sale | 2,000 | 11.31 | 22,620 |
| 2025-05-14 | GYRE | Sale | 20 | 11.30 | 226 |
| 2025-05-15 | GYRE | Sale | 2,000 | 10.68 | 21,360 |
| 2025-05-12 | GYRE | Sale | 2,000 | 10.56 | 21,120 |
| 2025-05-13 | GYRE | Sale | 2,000 | 11.37 | 22,740 |
| 2025-03-21 | GYRE | Sale | 174 | 10.00 | 1,740 |
| 2025-03-19 | GYRE | Sale | 2,000 | 10.13 | 20,260 |
| 2025-03-20 | GYRE | Sale | 2,000 | 10.09 | 20,180 |
| 2025-03-17 | GYRE | Sale | 2,000 | 12.09 | 24,180 |
| 2025-03-18 | GYRE | Sale | 242 | 10.24 | 2,478 |
| 2025-03-14 | GYRE | Sale | 2,000 | 12.31 | 24,620 |
| 2025-03-13 | GYRE | Sale | 2,000 | 11.80 | 23,600 |
| 2025-03-11 | GYRE | Sale | 2,000 | 11.40 | 22,800 |
| 2025-03-12 | GYRE | Sale | 2,000 | 11.74 | 23,480 |
| 2025-03-07 | GYRE | Sale | 2,000 | 11.77 | 23,534 |
| 2025-03-10 | GYRE | Sale | 2,000 | 10.14 | 20,280 |
| 2025-03-05 | GYRE | Sale | 2,000 | 10.98 | 21,960 |
| 2025-03-06 | GYRE | Sale | 2,000 | 10.80 | 21,600 |
| 2025-03-03 | GYRE | Sale | 2,000 | 11.23 | 22,460 |
| 2025-03-04 | GYRE | Sale | 2,000 | 10.86 | 21,720 |
| 2025-02-27 | GYRE | Sale | 2,000 | 11.33 | 22,660 |
| 2025-02-28 | GYRE | Sale | 2,000 | 11.41 | 22,820 |
| 2025-02-26 | GYRE | Sale | 2,000 | 11.63 | 23,260 |
| 2025-02-25 | GYRE | Sale | 2,000 | 11.37 | 22,740 |
| 2025-02-21 | GYRE | Sale | 2,000 | 12.22 | 24,440 |
| 2025-02-24 | GYRE | Sale | 2,000 | 11.06 | 22,120 |
| 2025-02-19 | GYRE | Sale | 2,000 | 12.29 | 24,580 |
| 2025-02-20 | GYRE | Sale | 2,000 | 12.40 | 24,800 |
| 2025-02-14 | GYRE | Sale | 2,000 | 11.94 | 23,880 |
| 2025-02-18 | GYRE | Sale | 2,000 | 12.49 | 24,980 |
| 2025-02-12 | GYRE | Sale | 2,000 | 11.49 | 22,980 |
| 2025-02-13 | GYRE | Sale | 2,000 | 11.69 | 23,380 |
| 2025-02-11 | GYRE | Sale | 1,878 | 11.52 | 21,634 |
| 2025-02-10 | GYRE | Sale | 2,000 | 11.90 | 23,800 |
| 2025-02-07 | GYRE | Sale | 2,000 | 12.16 | 24,320 |
| 2025-02-06 | GYRE | Sale | 2,000 | 12.85 | 25,700 |
| 2025-02-05 | GYRE | Sale | 2,000 | 12.62 | 25,230 |
| 2025-02-04 | GYRE | Sale | 2,000 | 11.62 | 23,240 |
| 2025-01-31 | GYRE | Sale | 2,000 | 11.51 | 23,020 |
| 2025-02-03 | GYRE | Sale | 2,000 | 11.47 | 22,940 |
| 2025-01-29 | GYRE | Sale | 2,000 | 11.43 | 22,860 |
| 2025-01-30 | GYRE | Sale | 2,000 | 11.37 | 22,740 |
| 2025-01-27 | GYRE | Sale | 2,000 | 11.18 | 22,360 |
| 2025-01-28 | GYRE | Sale | 2,000 | 11.51 | 23,020 |
| 2025-01-24 | GYRE | Sale | 2,000 | 10.89 | 21,780 |
| 2025-01-23 | GYRE | Sale | 2,000 | 10.49 | 20,980 |
| 2025-01-21 | GYRE | Sale | 2,000 | 10.85 | 21,700 |
| 2025-01-22 | GYRE | Sale | 2,000 | 10.63 | 21,260 |
| 2025-01-17 | GYRE | Sale | 2,000 | 10.72 | 21,440 |
| 2025-01-16 | GYRE | Sale | 2,000 | 10.71 | 21,420 |
| 2025-01-14 | GYRE | Sale | 2,000 | 10.39 | 20,780 |
| 2025-01-15 | GYRE | Sale | 2,000 | 10.85 | 21,700 |
| 2025-01-13 | GYRE | Sale | 56 | 10.10 | 565 |
| 2025-01-10 | GYRE | Sale | 1,057 | 10.02 | 10,591 |
| 2025-01-06 | GYRE | Sale | 941 | 10.16 | 9,560 |
| 2025-01-07 | GYRE | Sale | 1,275 | 10.02 | 12,775 |
| 2024-01-03 | GYRE | Sale | 833 | 11.85 | 9,871 |
| 2025-01-02 | GYRE | Sale | 2,000 | 12.40 | 24,800 |
| 2025-01-03 | GYRE | Sale | 1,167 | 11.03 | 12,872 |
| 2024-12-18 | GYRE | Sale | 2,000 | 11.64 | 23,280 |
| 2024-12-17 | GYRE | Sale | 2,000 | 11.09 | 22,170 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ma Songjiang (President of Gyre Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.